Eczema is an umbrella term for a group of conditions that result in skin irritation and inflammation. The most common form of ...

A subset of patients treated with delgocitinib cream 20 mg/g for moderate to severe chronic eczema achieved a “super-response,” by week 16, according to a presenter at the American Academy of ...

A new survey commissioned by Leo Pharma confirms there’s plenty of room in the market for its chronic hand eczema treatment ...

Contrary to some commonly held beliefs, current research shows that cutting out certain foods makes little difference in ...

Soothing eczema involves hydration, avoiding triggers, and stress management. Dermatology-approved treatments and following gentle skincare tips can help control symptoms and promote healthier, ...

The following is a summary of “Long-term safety and efficacy of delgocitinib cream for up to 52 weeks in adults with Chronic ...

A STRAY itch on the wrist, behind the thigh or on the cheek may seem mild at first, but it may reach a point where those with ...

Amgen’s $400 million eczema drug candidate has recorded two more phase 3 victories. The data drops provide more evidence that ...

This NIHR Collection brings together major studies on the prevention and treatment of childhood eczema. It finds that many ...

After scoring a long-awaited FDA approval last fall, Eli Lilly has launched a consumer-facing campaign to get the word out ...

LEO Pharma A/S, a global leader in medical dermatology, today presented late-breaking data showcasing responses in a subgroup ...